Life Sciences
How next-generation CRM will reshape the life sciences commercial model
CRM must evolve from a static map to a real-time guide for commercial teams.
CRM must become real-time and insight-driven.
How far has CRM come, and what held it back?
Systems recorded activity but rarely guided action.
Why are customer needs changing?
Clinicians want relevant, digital, on-demand engagement.
How decision-making in health care is shifting
How will AI disrupt CRM?
AI will recommend actions and personalize engagement.
What strategy does the industry need?
Invest in data, AI and new ways of working.
Summary
Next-generation CRM will make commercial models more responsive and effective.
Keep reading
Related articles
Article
How biopharma can get the right mix of people and technology for launch success
Biopharma companies need an end-to-end, AI-enabled launch strategy to succeed in a challenging market.
Article
How life sciences legal teams prepare for a technology-driven future
Emerging health technology creates new data flows and new legal and privacy questions for life sciences companies.
Article
What pharma supply chain transformation means for tax
Companies building resilient supply chains should involve tax and transfer pricing teams early.